On September 14-16, 2015, the U.S.-Mongolia workshop titled “Chronic Viral Hepatitis and Primary Liver Cancer” was organized at the Corporate Hotel and Convention Center in Ulaanbaatar, Mongolia. The bilateral workshop, featuring a partnership between Mongolian and U.S. medical professionals, aimed to review current advances in viral hepatitis, chronic liver disease and liver cancer, discussing the potential for U.S.-Mongolia research collaboration in these areas and mechanisms for future collaboration and trainings.
On September 14, 2015, the State Secretary of Health and Sports of Mongolia Ms. Ganchimeg G. and Economic and Commercial Section Chief at the U.S. Embassy in Mongolia Mr. John McDaniel made opening remarks.
In her speech, State Secretary Ganchimeg G. said that U.S.-Mongolian “joint efforts will contribute enormously in the reduction of morbidity and mortality caused by viral hepatitis in Mongolia.” Mr. John McDaniel emphasized the importance of this new partnership that will “make a big difference in the lives of Mongolians.”
The first day of the workshop touched upon epidemiology of hepatitis virus infections in Mongolia, immunology and host defense, and diagnosis and treatment. The second day continued with discussions on liver cancer and prevention collaboration.
As one of the first partnerships between the U.S. and Mongolian medical communities, several new research and collaboration efforts have been determined that hope to drastically reduce the harmful outcomes of chronic viral hepatitis and primary liver cancer in Mongolia.
